The DAFNE team from Hull & East Yorkshire NHS Hospitals Trust has had an abstract accepted for an oral presentation at the EASD this September. The abstract details the effect of DAFNE for individuals with Type 1 diabetes in terms of DKA admissions. The data reveal significant reductions in hospital DKA admission rates, indicating that DAFNE could play a vital role in a strategy to reduce DKA admissions.
"It's not dose adjustment for normal eating, it's dose adjustment for normal living"